Danaher Co. (NYSE:DHR) Shares Bought by Coastline Trust Co

Coastline Trust Co lifted its position in shares of Danaher Co. (NYSE:DHRFree Report) by 5.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,446 shares of the conglomerate’s stock after buying an additional 464 shares during the period. Coastline Trust Co’s holdings in Danaher were worth $2,185,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also made changes to their positions in the company. Drive Wealth Management LLC grew its holdings in Danaher by 3.1% during the 4th quarter. Drive Wealth Management LLC now owns 1,485 shares of the conglomerate’s stock worth $344,000 after acquiring an additional 44 shares in the last quarter. Apella Capital LLC raised its position in Danaher by 2.0% during the 3rd quarter. Apella Capital LLC now owns 2,332 shares of the conglomerate’s stock worth $579,000 after buying an additional 46 shares during the last quarter. Nations Financial Group Inc. IA ADV raised its position in Danaher by 0.8% during the 1st quarter. Nations Financial Group Inc. IA ADV now owns 6,064 shares of the conglomerate’s stock worth $1,779,000 after buying an additional 46 shares during the last quarter. Peddock Capital Advisors LLC increased its holdings in shares of Danaher by 0.9% in the 3rd quarter. Peddock Capital Advisors LLC now owns 5,523 shares of the conglomerate’s stock valued at $1,370,000 after purchasing an additional 47 shares in the last quarter. Finally, IMS Capital Management increased its holdings in shares of Danaher by 0.4% in the 2nd quarter. IMS Capital Management now owns 11,046 shares of the conglomerate’s stock valued at $2,651,000 after purchasing an additional 49 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of DHR stock traded down $1.81 during trading hours on Tuesday, reaching $245.98. 2,955,633 shares of the company’s stock were exchanged, compared to its average volume of 2,751,940. Danaher Co. has a fifty-two week low of $182.09 and a fifty-two week high of $259.00. The stock has a market capitalization of $182.16 billion, a P/E ratio of 38.78, a P/E/G ratio of 3.80 and a beta of 0.83. The business has a fifty day moving average price of $248.33 and a 200-day moving average price of $230.34. The company has a quick ratio of 1.37, a current ratio of 1.68 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHRGet Free Report) last issued its quarterly earnings results on Tuesday, January 30th. The conglomerate reported $2.09 EPS for the quarter, topping analysts’ consensus estimates of $1.91 by $0.18. Danaher had a return on equity of 12.25% and a net margin of 17.26%. The company had revenue of $6.41 billion during the quarter, compared to analyst estimates of $6.10 billion. During the same period in the previous year, the company earned $2.87 earnings per share. The company’s quarterly revenue was down 10.2% compared to the same quarter last year. Analysts predict that Danaher Co. will post 7.62 EPS for the current fiscal year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 26th. Investors of record on Thursday, March 28th will be paid a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.44%. This is a positive change from Danaher’s previous quarterly dividend of $0.24. The ex-dividend date is Wednesday, March 27th. Danaher’s dividend payout ratio is presently 16.90%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on DHR shares. TheStreet raised shares of Danaher from a “c+” rating to a “b-” rating in a research note on Friday, December 8th. StockNews.com downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research report on Wednesday, January 31st. Royal Bank of Canada raised their price target on shares of Danaher from $254.00 to $282.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 31st. JPMorgan Chase & Co. raised their price target on shares of Danaher from $250.00 to $270.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 20th. Finally, HSBC assumed coverage on shares of Danaher in a report on Monday, December 18th. They issued a “hold” rating for the company. Seven research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to data from MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and an average target price of $266.00.

Get Our Latest Analysis on DHR

Insider Activity at Danaher

In related news, SVP Georgeann Couchara sold 2,622 shares of the company’s stock in a transaction on Tuesday, February 13th. The stock was sold at an average price of $242.67, for a total value of $636,280.74. Following the completion of the transaction, the senior vice president now directly owns 4,244 shares in the company, valued at $1,029,891.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Danaher news, SVP Daniel Raskas sold 23,757 shares of the company’s stock in a transaction on Monday, February 26th. The stock was sold at an average price of $252.00, for a total value of $5,986,764.00. Following the sale, the senior vice president now directly owns 38,102 shares in the company, valued at $9,601,704. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Georgeann Couchara sold 2,622 shares of the stock in a transaction on Tuesday, February 13th. The stock was sold at an average price of $242.67, for a total value of $636,280.74. Following the sale, the senior vice president now owns 4,244 shares in the company, valued at approximately $1,029,891.48. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 32,957 shares of company stock worth $8,265,802. 11.10% of the stock is owned by corporate insiders.

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Recommended Stories

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.